HIV and AIDS
July 22, 2022
Novel HIV combination therapies could prevent viral escape and rebound
New research by scientists at the University of Washington, the Max Planck Institute for Dynamics and Self-Organization and the University of Cologne indicates that carefully designed cocktails of broadly neutralizing antibodies could help treat HIV while minimizing the risk of the virus evolving to “escape” treatment.
February 16, 2022
Unexpected findings detailed in new portrait of HIV
Using powerful tools and techniques developed in the field of structural biology, researchers at the University of Washington and Scripps Research have discovered new details about the human immunodeficiency virus, HIV. The findings bring into focus the basic architecture of the virus just above and below its surface and may help in the design and…
November 20, 2018
Mobile health has power to transform HIV/AIDS nursing
The abundance of personal smartphones in southern African countries got University of Washington professor Sarah Gimbel thinking: What if these phones were used by front-line health workers — namely nurses — to collect and analyze data on patients living with HIV or AIDS to improve their care?
August 26, 2014
Health Digest: Ebola outbreak, HIV persistence, kids’ sleep routines
UW Health Sciences News Digest: Ebola outbreak, HIV persistence, back-to-school sleep routines
July 30, 2014
Dissolvable fabric loaded with medicine might offer faster protection against HIV
University of Washington bioengineers have discovered a potentially faster way to deliver a topical drug that protects women from contracting HIV. Their method spins the drug into silk-like fibers that quickly dissolve when in contact with moisture, releasing higher doses of the drug than possible with other materials.
July 29, 2014
Health Sciences News Digest 7.29.2014
News from the UW Health Sciences: Alzheimer’s impact on our aging population, hunger cues, trauma treatment study, avoiding burnout, training new neuroscientists, an AIDS-free generation
July 10, 2013
Functional genomics lab to predict potential AIDS vaccines efficacy and find protection markers
Funded by the NIH at $15 million over five years, the lab will be a national resource to evaluate candidate vaccines from studies around the country.
March 20, 2013
2013 Canada Gairdner Global Health Award goes to King Holmes for STD work
Holmes was honored for his groundbreaking work on sexually transmitted diseases, including HIV/AIDS, chlamydia, genital herpes, gonorrhea and human papilloma virus.
November 30, 2012
Electrically spun fabric offers dual defense against pregnancy, HIV
Electrically spun cloth with nanometer-sized fibers show promise as a cheap, versatile platform to simultaneously offer contraception and prevent HIV. New funding from the Bill & Melinda Gates Foundation will further test the system’s versatility and feasibility.
July 16, 2012
UW study plays pivotal role in todays FDA approval of HIV prevention drug
In evaluating whether to allow Truvada® to be prescribed for HIV prevention the FDA reviewed evidence from two studies. The largest was conducted by the UWs International Clinical Research Center.
July 11, 2012
Groundbreaking research paves way for HIV prevention drug approval
The UW International Clinical Research Center played a key role in examining Truvada’s effectiveness for HIV prevention. The center’s director Connie Celum talks about the impact of the findings in a Q & A.
December 7, 2011
UW scientist gets major boost in search for HIV vaccine
Dr. Shiu-Lok Hu and his colleagues are looking to generate protective antibodies targeting a part of the HIV virus that binds to immune cells. This segment is widely considered to be the Achilles heel of the virus
October 4, 2011
Hormonal contraception use doubles HIV risk, according to UW study in Lancet
A UW-led study published in The Lancet Infectious Diseases shows a troubling link between hormonal contraception and HIV. The study is getting widespread press coverage because of the popularity of injectable birth control like Depo-Provera in parts of Africa hardest hit by the AIDS epidemic.
